Deliang Guo

8.1k total citations · 1 hit paper
76 papers, 4.1k citations indexed

About

Deliang Guo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Deliang Guo has authored 76 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 39 papers in Cancer Research and 22 papers in Surgery. Recurrent topics in Deliang Guo's work include Cancer, Lipids, and Metabolism (21 papers), Cholesterol and Lipid Metabolism (14 papers) and Lipid metabolism and biosynthesis (11 papers). Deliang Guo is often cited by papers focused on Cancer, Lipids, and Metabolism (21 papers), Cholesterol and Lipid Metabolism (14 papers) and Lipid metabolism and biosynthesis (11 papers). Deliang Guo collaborates with scholars based in United States, China and France. Deliang Guo's co-authors include Feng Geng, Xiang Cheng, Chunming Cheng, Arnab Chakravarti, Paul S. Mischel, Erica H. Bell, Peng Ru, Xiaoning Wu, Xiaokui Mo and Jianying Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Deliang Guo

73 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid metabolism reprogramming and its potential targets in cancer

2018 615 citations Chunming Cheng, Feng Geng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deliang Guo United States	29	2.6k	2.0k	615	589	544	76	4.1k
Dan Y. Gui United States	14	3.3k 1.3×	2.4k 1.2×	551 0.9×	223 0.4×	400 0.7×	25	4.5k
William W. Wheaton United States	9	3.2k 1.2×	2.2k 1.1×	790 1.3×	325 0.6×	205 0.4×	9	4.3k
Zachary E. Stine United States	16	3.1k 1.2×	2.5k 1.2×	791 1.3×	199 0.3×	303 0.6×	23	4.6k
Jiangbin Ye United States	25	3.2k 1.2×	1.7k 0.8×	444 0.7×	270 0.5×	309 0.6×	41	4.5k
Irina Tchernyshyov United States	10	3.6k 1.4×	3.4k 1.7×	499 0.8×	230 0.4×	355 0.7×	10	5.2k
Koen Brusselmans Belgium	21	4.2k 1.6×	4.0k 2.0×	840 1.4×	772 1.3×	483 0.9×	24	6.8k
Yanhua Zheng United States	27	3.8k 1.5×	2.2k 1.1×	782 1.3×	291 0.5×	212 0.4×	34	5.2k
Ya’an Kang United States	31	2.2k 0.8×	1.7k 0.8×	1.4k 2.3×	296 0.5×	186 0.3×	53	3.9k
Simon Wigfield United Kingdom	20	2.4k 0.9×	1.3k 0.7×	407 0.7×	216 0.4×	230 0.4×	25	3.2k
Barrie Peck United Kingdom	16	2.1k 0.8×	1.6k 0.8×	426 0.7×	250 0.4×	368 0.7×	22	3.2k

Countries citing papers authored by Deliang Guo

Since Specialization

Citations

This map shows the geographic impact of Deliang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deliang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deliang Guo more than expected).

Fields of papers citing papers by Deliang Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deliang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deliang Guo. The network helps show where Deliang Guo may publish in the future.

Co-authorship network of co-authors of Deliang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Deliang Guo. A scholar is included among the top collaborators of Deliang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deliang Guo. Deliang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Deliang, et al.. (2025). Biodegradation performance of azo dyes based on Fe-Mn@C dual-template molecularly imprinted sensor. Journal of Environmental Sciences. 159. 546–554.

He, Liqing, Feng Geng, Xinmin Yin, et al.. (2025). Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth. Science Advances. 11(16). eadq0334–eadq0334. 1 indexed citations

Guo, Deliang, et al.. (2024). Integrated tea polyphenols and polydopamine functionalized graphene anode for improved bioelectricity generation and Cr(VI) reduction in microbial fuel cells. Chemosphere. 363. 142858–142858. 2 indexed citations

Oo, Adrian, Yujie Liu, Zhaojun Qiu, et al.. (2024). The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Nature Communications. 15(1). 4667–4667. 6 indexed citations

Zhang, Rui, Meixia Pan, Feng Geng, et al.. (2024). STAT3 activation of SCAP-SREBP-1 signaling upregulates fatty acid synthesis to promote tumor growth. Journal of Biological Chemistry. 300(6). 107351–107351. 9 indexed citations

Geng, Feng, Yaogang Zhong, Étienne Lefai, et al.. (2023). SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells. Cell Reports. 42(7). 112790–112790. 25 indexed citations

Li, Zaibo, Xiaokui Mo, Bhaskar Kallakury, et al.. (2023). Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research. Cells. 12(19). 2388–2388. 3 indexed citations

Cheng, Chunming, Feng Geng, Yaogang Zhong, et al.. (2022). Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nature Metabolism. 4(5). 575–588. 90 indexed citations

Cheng, Chunming, et al.. (2022). Glutamine-released ammonia acts as an unprecedented signaling molecule activating lipid production. Genes & Diseases. 10(2). 307–309. 5 indexed citations

10.

Xia, Peng, Hao Zhang, Kequan Xu, et al.. (2022). YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner. Frontiers in Oncology. 12. 873020–873020. 17 indexed citations

11.

Wang, Haitao, Pei Ma, Pengpeng Liu, et al.. (2021). lncRNA SNHG6 promotes hepatocellular carcinoma progression by interacting with HNRNPL/PTBP1 to facilitate SETD7/LZTFL1 mRNA destabilization. Cancer Letters. 520. 121–131. 23 indexed citations

12.

Guo, Deliang, Yang Gu, Pengpeng Liu, et al.. (2021). A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma. Genes & Diseases. 9(4). 845–848. 3 indexed citations

13.

Cheng, Xiang, Feng Geng, & Deliang Guo. (2020). DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy. Molecular & Cellular Oncology. 7(6). 1805257–1805257. 15 indexed citations

14.

Zhu, Qian, Guoliang Qiao, Chang Xu, et al.. (2017). Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study. Cancer Management and Research. Volume 9. 525–537. 15 indexed citations

15.

London, Wendy B., Elena B. Hawryluk, Deliang Guo, et al.. (2017). Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 52(7). 989–997. 10 indexed citations

16.

Tang, Jie, Yun Li, Kai Liu, et al.. (2017). Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma. Minerva Medica. 109(1). 15–23. 72 indexed citations

17.

Geng, Feng, Xiang Cheng, Xiaoning Wu, et al.. (2016). Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis. Clinical Cancer Research. 22(21). 5337–5348. 244 indexed citations

18.

Guo, Deliang, Erica H. Bell, Paul S. Mischel, & Arnab Chakravarti. (2014). Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer. Current Pharmaceutical Design. 20(15). 2619–2626. 254 indexed citations

19.

Niehr, Franziska, Erika von Euw, Narsis Attar, et al.. (2011). Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations. Journal of Translational Medicine. 9(1). 76–76. 78 indexed citations

20.

Ai, Ding, Yi Fu, Deliang Guo, et al.. (2007). Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proceedings of the National Academy of Sciences. 104(21). 9018–9023. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact